US patent for miniature diagnostics technology:
This article was originally published in Clinica
The University of Washington has received a US patent covering a chemical component separation technology, which could lead to the development of small, portable, easy-to-use medical diagnostic devices capable of performing a wide variety of tests using less than a drop of blood. The H-Filters technique can be used as part of microfluid integrated circuits to separate small soluble components from larger particles. The new method, which could replace the cumbersome and time-consuming centrifugation steps needed for most blood tests, is being commercialised under an exclusive license by Micronics, the Redmond, Washington-based developer of microfluid technologies.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.